Membership required to view content. that they will seek approval for the newly developed COVID-19 vaccine is a shot in the arm for unsure global markets. Today’s market activity reflects participants ambivalence, weighing the game changing vaccine with economic fallout from impending lockdown measures. Pfizer’s collaboration has yielded a vaccine that is apparently over 90% effective, and safe.
Pfizer says they will apply for Emergency Use Authorization (EUA) with the FDA imminently, after the required safety milestone is achieved. Pfizer, with a $50 billion+ market cap has an historical working relationship with the FDA, having gained approval for some of the most widely used drugs, like Lipitor, Viagra, or Zoloft. The vaccine trial began in…
Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!
